These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 16886269)

  • 1. Something old, something new...
    Smith S
    Leuk Lymphoma; 2006 Apr; 47(4):576-7. PubMed ID: 16886269
    [No Abstract]   [Full Text] [Related]  

  • 2. Vinorelbine, gemcitabine, procarbazine and prednisone (ViGePP) as salvage therapy in relapsed or refractory aggressive non-Hodgkin's lymphoma (NHL): results of a phase II study conducted by the Gruppo Italiano per lo Studio dei Linfomi.
    Di Renzo N; Brugiatelli M; Montanini A; Vigliotti ML; Cervetti G; Liberati AM; Luminari S; Spedini P; Giglio G; Federico M
    Leuk Lymphoma; 2006 Mar; 47(3):473-9. PubMed ID: 16396771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gemcitabine and vinorelbine combination is effective in both as a salvage and mobilization regimen in relapsed or refractory Hodgkin lymphoma prior to ASCT.
    Suyanı E; Sucak GT; Akı ŞZ; Yeğin ZA; Özkurt ZN; Yağcı M
    Ann Hematol; 2011 Jun; 90(6):685-91. PubMed ID: 21072518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gemcitabine and vinorelbine chemotherapy for refractory or relapsing aggressive non-Hodgkin lymphoma.
    Sivam V; Cook L; Hughes G; Karadimitris A; Marks AJ; Matthey F; Naresh KN; Szydlo RM; Yarranton H; Kanfer EJ; Macdonald DH
    Hematol Oncol; 2012 Dec; 30(4):214-5. PubMed ID: 22422565
    [No Abstract]   [Full Text] [Related]  

  • 5. Bendamustine salvage for the treatment of relapsed Hodgkin's lymphoma after allogeneic bone marrow transplantation.
    Mian M; Farsad M; Pescosta N; Casini M; Cavattoni IM; Deola S; Cortelazzo S
    Ann Hematol; 2013 Jan; 92(1):121-3. PubMed ID: 22820997
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of topotecan, vinorelbine, thiotepa and gemcitabine chemotherapy in relapsed/refractory adult acute leukemia.
    Srour SA; Borders EB; Cherry MA; Holter J; Herman T; Selby GB
    Leuk Lymphoma; 2015; 56(10):2962-4. PubMed ID: 25721752
    [No Abstract]   [Full Text] [Related]  

  • 7. Gemcitabine plus vinorelbine as an effective salvage chemotherapeutic regimen in advanced Hodgkin lymphoma.
    Chen JH; Chang PY; Yao NS
    Hematol Oncol Stem Cell Ther; 2009; 2(2):371-2. PubMed ID: 20118065
    [No Abstract]   [Full Text] [Related]  

  • 8. Bortezomib in combination with IGEV chemotherapy regimen for a primary refractory Hodgkin's lymphoma of bone.
    Ding L; Wang HX; Xue M; Zhu L; Liu J; Yan HM; Duan LN; Wang ZD
    Leuk Res; 2009 Sep; 33(9):e170-2. PubMed ID: 19403168
    [No Abstract]   [Full Text] [Related]  

  • 9. Gemcitabine, vinorelbine and prednisone for refractory or relapsed aggressive lymphoma, results of a phase II single center study.
    Müller-Beissenhirtz H; Kasper C; Nückel H; Dührsen U
    Ann Hematol; 2005 Nov; 84(12):796-801. PubMed ID: 16041531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gemcitabine is active in relapsed Hodgkin's disease.
    Lucas JB; Horwitz SM; Horning SJ; Sayegh A
    J Clin Oncol; 1999 Aug; 17(8):2627-8. PubMed ID: 10561333
    [No Abstract]   [Full Text] [Related]  

  • 11. Ifosfamide, gemcitabine, and vinorelbine: a new induction regimen for refractory and relapsed Hodgkin's lymphoma.
    Santoro A; Magagnoli M; Spina M; Pinotti G; Siracusano L; Michieli M; Nozza A; Sarina B; Morenghi E; Castagna L; Tirelli U; Balzarotti M
    Haematologica; 2007 Jan; 92(1):35-41. PubMed ID: 17229633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Successful outpatient treatment with chemotherapy of weekly gemcitabine and vinorelbine for a patient with recurrent lung cancer].
    Kawasaki Y; Kato K; Kobayashi K; Yano S; Saito S; Fukuda M; Miyata M; Shimizu E
    Gan To Kagaku Ryoho; 2002 Jan; 29(1):107-9. PubMed ID: 11816464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is gemcitabine plus vinorelbine active in second-line chemotherapy of metastatic breast cancer? a single-center phase 2 study.
    Rossi E; Perrone F; Labonia V; Landi G; Nuzzo F; Amabile G; Gridelli C; Di Maio M; D'Aiuto G; de Matteis A
    Oncology; 2003; 64(4):479-80. PubMed ID: 12759551
    [No Abstract]   [Full Text] [Related]  

  • 14. Combination chemotherapy of gemcitabine and vinorelbine in patients with advanced non-small cell lung cancer.
    Buyukcelik A; Utkan G; Yalcin B; Demirkazik A
    Lung Cancer; 2004 Dec; 46(3):377-8. PubMed ID: 15541824
    [No Abstract]   [Full Text] [Related]  

  • 15. Gemcitabine and vinorelbine as a salvage regimen for relapse in Hodgkin lymphoma after autologous hematopoietic stem cell transplantation.
    Ozkaynak MF; Jayabose S
    Pediatr Hematol Oncol; 2004 Mar; 21(2):107-13. PubMed ID: 15160509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multicenter phase 2 study of risk-adjusted salvage chemotherapy incorporating vinorelbine and gemcitabine for relapsed and refractory lymphoma.
    Pasricha SR; Grigg A; Catalano J; Leahy M; Underhill C; Arthur C; D'Rozario J; Lowenthal R; Reed K; Spencer A
    Cancer; 2008 Dec; 113(11):3192-8. PubMed ID: 18932253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vinorelbine and prednisone in frail elderly patients with intermediate-high grade non-Hodgkin's lymphomas.
    Tirelli U; Balzarotti M; Uziel L; Ferreri AJ; Santoro A; Spina M
    Ann Oncol; 2006 Mar; 17(3):533. PubMed ID: 16291585
    [No Abstract]   [Full Text] [Related]  

  • 18. The feasibility of using topotecan, vinorelbine, thiotepa and gemcitabine (TVTG) in adult patients with relapsed/refractory acute lymphoblastic leukaemia/lymphoma.
    Hiwarkar P; Arkenau HT; Treleaven J; Morgan G; Potter M; Ethell M
    Leukemia; 2008 Aug; 22(8):1627-9. PubMed ID: 18305560
    [No Abstract]   [Full Text] [Related]  

  • 19. Resolution of psoriatic skin lesions after chemotherapy with gemcitabine and vinorelbine.
    Genvresse I; Flath B; Akrivakis K; Beinert T; Späth-Schwalbe E; Possinger K
    Br J Dermatol; 2000 Dec; 143(6):1326-7. PubMed ID: 11122048
    [No Abstract]   [Full Text] [Related]  

  • 20. [Strategy in the treatment of anthracycline-resistant breast cancer].
    Xu BH
    Zhonghua Zhong Liu Za Zhi; 2007 Apr; 29(4):241-4. PubMed ID: 17760246
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.